Ultivue: Mike Sismour, Mark Rees
Ultivue, a company specializing in multiplex biomarker assays for tissue phenotyping and digital pathology, has appointed Mike Sismour as vice president, research, and Mark Rees as vice president, corporate development.
Sismour most recently served as chief scientist/head of genomics R&D at Beckman Coulter Life Science. He was a National Institutes of Health Ruth L. Kirschstein postdoc at Harvard Medical School and a fellow at Harvard's Wyss Institute.
Rees most recently worked for StatLab where he helped create a diagnostic division. He previously held leadership roles in commercial development, scientific affairs, and R&D at Enzo Life Sciences, Leica Biosystems (Danaher), and Novocastra Laboratories.